Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-123 |
Sentence |
denotes |
Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: |
T2 |
124-151 |
Sentence |
denotes |
An Epidemio-Clinical Study. |
T3 |
152-160 |
Sentence |
denotes |
Purpose: |
T4 |
161-406 |
Sentence |
denotes |
The present study was undertaken to investigate epidemiological distribution, clinical manifestation, co morbid status, treatment strategy and case fatality index of emerging COVID-19 infection at SMS Medical College Hospital, Jaipur, Rajasthan. |
T5 |
407-588 |
Sentence |
denotes |
It also evaluated efficacy of hydroxychloroquine (HCQ) in treatment of patients and risk of serious adverse outcomes in patients with COVID-19 in relation to their co morbid status. |
T6 |
589-611 |
Sentence |
denotes |
Materials and methods: |
T7 |
612-780 |
Sentence |
denotes |
In an attempt to provide extensive information pertaining to epidemiological and clinical characteristics of COVID-19, the present study was undertaken on 522 patients. |
T8 |
781-966 |
Sentence |
denotes |
The patients were COVID-19 confirmed positive by genomic analysis through Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) at SMS Medical College and Attached Hospitals, Jaipur. |
T9 |
967-1244 |
Sentence |
denotes |
The indoor admitted patient's information inclusive of demographic profile (age, sex, nationality, residence), date of confirmation for positive COVID-19 case, travel/ exposure history, date of recovery/ death, clinical features, co morbidities and treatment plan was recorded. |
T10 |
1245-1357 |
Sentence |
denotes |
A serial follow-up of recovered patients to evaluate infective period of the disease was also part of the study. |
T11 |
1358-1366 |
Sentence |
denotes |
Results: |
T12 |
1367-1478 |
Sentence |
denotes |
A total of 522 patients of laboratory confirmed COVID-19 test by RT-PCR at SMS Hospitals, Jaipur were assessed. |
T13 |
1479-1586 |
Sentence |
denotes |
Among the confirmed cases, most of patients were young adult in the age group with mean age of 35.42 years. |
T14 |
1587-1775 |
Sentence |
denotes |
22.41% patients were below 20 years of age, majority of patients (58.80%) were in the age range of 21 to 50 years and only 18.79% patient population was in the age range of above 50 years. |
T15 |
1776-1885 |
Sentence |
denotes |
Females (39.08%) were affected less than males (60.91%) with an average sex ratio of female: male being 0.64. |
T16 |
1886-2284 |
Sentence |
denotes |
Out of the total analyzed patients, only 24.32% patients were symptomatic, among them fever (55.90%), cough (52.75%), sore throat (49.60%) and shortness of breath (46.45%) were the most common presenting clinical manifestations while a few patients also had symptoms of headache (26.77%), chest pain (6.29%) and other symptoms (7.87%) like pain abdomen, fatigue, joints pain, altered sensorium etc. |
T17 |
2285-2343 |
Sentence |
denotes |
Most of symptomatic patients belonging to older age group. |
T18 |
2344-2493 |
Sentence |
denotes |
An average of 40.40% patient population of above 50 years of age, were symptomatic while none of the patients below 10 years of age were symptomatic. |
T19 |
2494-2561 |
Sentence |
denotes |
13.98% patients had some or the other underlying co morbid disease. |
T20 |
2562-2862 |
Sentence |
denotes |
The most prevalent co morbidity was hypertension (42.46%) followed by Diabetes mellitus (39.72%), Old k-chest (20.54%), COPD/ Bronchial Asthma (16.43%), Coronary artery disease (13.69%), Chronic kidney disease (13.69%) and Valvular heart disease (6.84%) distributed in co morbid patients of COVID-19. |
T21 |
2863-3050 |
Sentence |
denotes |
60.27% of patient population with underlying co morbid conditions were more prone to develop symptomatology complex as compared to that observed in patients with no co morbidity (18.42%). |
T22 |
3051-3134 |
Sentence |
denotes |
116 patients had recovered with effective treatment till the date of data analysis. |
T23 |
3135-3310 |
Sentence |
denotes |
Time of recovery was counted from the date of positive report to 1st negative report of oropharyngeal sample by RT-PCR for COVID-19 with an average recovery time of 8.15 days. |
T24 |
3311-3482 |
Sentence |
denotes |
23.27% patients recovered within 5 days, while 52.58% patients took about 6-10 days, 23.27% patients took 11-15 days and remaining 0.86% took more than 16 days to recover. |
T25 |
3483-3635 |
Sentence |
denotes |
In the present study 15 patients had died till analysis of data, among the deceased, 73.33% were above 50 year of age with a male preponderance (66.6%). |
T26 |
3636-3779 |
Sentence |
denotes |
Interestingly, all deceased (100%) had presented with clinical manifestations of COVID-19 and all had underlying multiple co morbid conditions. |
T27 |
3780-3900 |
Sentence |
denotes |
Majority of patients had early mortality after admission to hospital with two third death account in initial three days. |
T28 |
3901-4145 |
Sentence |
denotes |
Asymptomatic patients (cases) treated with HCQ recovered early (average recovery time =5.4 days) compared to asymptomatic patients who did not receive any treatment (control group) and had longer recovery time (average recovery time =7.6 days). |
T29 |
4146-4157 |
Sentence |
denotes |
Conclusion: |
T30 |
4158-4259 |
Sentence |
denotes |
The varied spectra of COVID-19 mostly affects young adult age group (third to fifth decades of life). |
T31 |
4260-4388 |
Sentence |
denotes |
Interestingly, early age group was also affected in significant proportion when compared with similar data from other countries. |
T32 |
4389-4474 |
Sentence |
denotes |
It was observed that male population seemed to be was more prone to getting infected. |
T33 |
4475-4662 |
Sentence |
denotes |
Majority of COVID-19 positive patients (nearly three-fourth) were asymptomatic (mostly in young age range) at the time of diagnosis, which poses a major challenge for health care workers. |
T34 |
4663-4782 |
Sentence |
denotes |
Fever, cough, sore throat and shortness of breath were major symptoms that could be detected in such COVID-19 patients. |
T35 |
4783-4858 |
Sentence |
denotes |
Symptomatic clinical manifestations were more common in old age population. |
T36 |
4859-4991 |
Sentence |
denotes |
Infectivity was higher in patients that had underlying co morbid disease, especially in patients with multiple co morbid conditions. |
T37 |
4992-5090 |
Sentence |
denotes |
Symptomatic presentation of COVID-19 was observed to be higher in patients with co morbid disease. |
T38 |
5091-5163 |
Sentence |
denotes |
Average recovery time from COVID-19 was 8 days with effective treatment. |
T39 |
5164-5313 |
Sentence |
denotes |
Mortality in COVID-19 was higher in old age population, male gender, symptomatic and co morbid patients as compared to other similarly matched group. |
T40 |
5314-5443 |
Sentence |
denotes |
Most of mortality was noted within first few days of admission, suggestive of early mortality due to the primary disease process. |
T41 |
5444-5536 |
Sentence |
denotes |
Treatment with HCQ had early recovery without effectively influencing the overall mortality. |